NeuroPathway Readiness Checklist
Complete path to market-ready licensing
Investment timeline: 18 months to full market readiness
MHRA Medical Device Registration
criticalRegister NeuroPathway as Class IIa medical device under UK MDR 2002
Clinical Safety Case (DCB0129)
criticalDocument all clinical risks, hazards, and mitigation strategies
Clinical Risk Management (DCB0160)
criticalEstablish ongoing hazard monitoring and incident reporting processes
UKCA Marking Application
criticalApply for UKCA marking (required for UK market)
AI Model Documentation
criticalDocument training data, validation metrics, bias testing per MHRA ML principles
Predetermined Change Control Plans
highCreate ML update and change control documentation
Technical File Compilation
criticalAssemble complete technical file with design specs, risk analysis, clinical evaluation
Notified Body Assessment
criticalEngage UK-approved notified body for conformity assessment
Phase 1: Foundation (Months 1-3)
Focus: DPIA, DSPT compliance, insurance, clinical safety case, security audits
Phase 2: Validation (Months 4-6)
Focus: NHS/school pilots, clinical validation, user testing, AI bias audit
Phase 3: Regulatory (Months 7-12)
Focus: MHRA submission, NHS Digital API access, NICE evidence, ISO 27001
Phase 4: Launch (Months 12-18)
Focus: NHS App Library, commercial contracts, scale infrastructure, marketing